Siao Muk Cheng

BIRC5/Survivin is a novel ATG12–ATG5 conjugate interactor and an autophagy-induced DNA damage suppressor in human cancer and mouse embryonic fibroblast cells

Tzu‐Yu Lin, Hsiu-Han Chan, Shang‐Hung Chen et al. · Autophagy · 2019 · 143 citations · Full text

<scp>YM155</scp> down‐regulates survivin and <scp>XIAP</scp>, modulates autophagy and induces autophagy‐dependent <scp>DNA</scp> damage in breast cancer cells

Siao Muk Cheng, Yung-Chieh Chang, C Y Liu et al. · British Journal of Pharmacology · 2014 · 92 citations · Full text

Inhibition of HDAC3- and HDAC6-Promoted Survivin Expression Plays an Important Role in SAHA-Induced Autophagy and Viability Reduction in Breast Cancer Cells

Jane Ying-Chieh Lee, Ching-Wen Kuo, Shing-Ling Tsai et al. · Frontiers in Pharmacology · 2016 · 64 citations · Full text

Mitophagy, Breast Oncology, Chemoprevention Strategy +18

The SMAC mimetic LCL161 is a direct ABCB1/MDR1-ATPase activity modulator and BIRC5/Survivin expression down-regulator in cancer cells

Yung-Chieh Chang, Sree Karani Kondapuram, Tsung-Han Yang et al. · Toxicology and Applied Pharmacology · 2020 · 45 citations

Tumor Biology, Smac Mimetic Lcl161, Birc5/survivin Expression Down-regulator +12

HDAC2 and HDAC5 Up-Regulations Modulate Survivin and miR-125a-5p Expressions and Promote Hormone Therapy Resistance in Estrogen Receptor Positive Breast Cancer Cells

Wen-Tsung Huang, Yu‐Hsuan Tsai, Shang‐Hung Chen et al. · Frontiers in Pharmacology · 2017 · 35 citations · Full text